| Literature DB >> 33282820 |
Ahmed Ferchiou1, Remy Bornet1, Guillaume Lhermie1, Didier Raboisson1.
Abstract
As of mid-2020, eradicating COVID-19 seems not to be an option, at least in the short term. The challenge for policy makers consists of implementing a suitable approach to contain the outbreak and limit extra deaths without exhausting healthcare forces while mitigating the impact on the country's economy and on individuals' well-being. To better describe the trade-off between the economic, societal and public health dimensions, we developed an integrated bioeconomic optimization approach. We built a discrete age-structured model considering three main populations (youth, adults and seniors) and 8 socio-professional characteristics for the adults. Fifteen lockdown exit strategies were simulated for several options: abrupt or progressive (4 or 8 weeks) lockdown lift followed by total definitive transitory final unlocking. Three values of transmission rate (Tr) were considered to represent individuals' barrier gesture compliance. Optimization under constraint to find the best combination of scenarios and options was performed on the minimal total cost for production losses due to contracted activities and hospitalization in the short and mid-term, with 3 criteria: mortality, person-days locked and hospital saturation. The results clearly show little difference between the scenarios based on the economic impact or the 3 criteria. This means that policy makers should focus on individuals' behaviors (represented by the Tr value) more than on trying to optimize the lockdown strategy (defining who is unlocked and who is locked). For a given Tr, the choices of scenarios permit the management of the hospital saturation level with regard to both its intensity and its duration, which remains a key point for public health. The results highlight the need for behavioral or experimental economics to address COVID-19 issues through a better understanding of individual behavior motivations and the identification of ways to improve biosecurity compliance.Entities:
Keywords: COVID-19; SIR; bioeconomic model; policy simulation; public health
Year: 2020 PMID: 33282820 PMCID: PMC7705347 DOI: 10.3389/fpubh.2020.606371
Source DB: PubMed Journal: Front Public Health ISSN: 2296-2565
Figure 1Compartmental model. S, susceptible; E, exposed; Ip, infectious in the prodromic phase; Ia, asymptomatic infectious; Ips, paucisymptomatic infectious; Ims, symptomatic infectious with mild symptoms; Iss, symptomatic infectious with severe symptoms; ICU, severe case admitted to ICU; H, severe case admitted to the hospital but not in intensive care; Rep, recovered without economic activity; Rep, recovered with economic activity; D, deceased.
Description of the socio-professional categories and the lockdown exit scenarios.
| Class of epidemiologic risk category | Child | Adult | Adult | Seniors | Adult | Adult | Adult | Adult | Adult | Adult | |
| Inhabitants number | 80,500 | 75,000 | 43,500 | 64,500 | 26,775 | 26,775 | 33,500 | 41,650 | 41,650 | 41,650 | |
| ActReleasePopi, Lj | L0 | 3% | 3% | 3% | 3% | 100% | 100% | 3% | 3% | 3% | 3% |
| L1 | 3% | 3% | 3% | 3% | 100% | 100% | 50% | 50% | 50% | 50% | |
| L2 | 3% | 3% | 3% | 3% | 100% | 100% | 75% | 75% | 75% | 75% | |
| L3 | 3% | 3% | 3% | 3% | 100% | 100% | 100% | 50% | 50% | 50% | |
| L4 | 3% | 3% | 3% | 3% | 100% | 100% | 50% | 100% | 100% | 50% | |
| L5 | 3% | 3% | 3% | 3% | 100% | 100% | 50% | 50% | 50% | 100% | |
| L6 | 100% | 3% | 25% | 20% | 100% | 100% | 50% | 50% | 50% | 50% | |
| L7 | 100% | 3% | 25% | 20% | 100% | 100% | 75% | 75% | 75% | 75% | |
| L8 | 100% | 3% | 25% | 20% | 100% | 100% | 100% | 50% | 50% | 50% | |
| L9 | 100% | 3% | 25% | 20% | 100% | 100% | 50% | 100% | 100% | 50% | |
| L10 | 100% | 3% | 25% | 20% | 100% | 100% | 50% | 50% | 50% | 100% | |
| L11 | 100% | 3% | 25%wc | 25%wc | 100% | 100% | 40%wc | 40%wc | 40%wc | 40%wc | |
| L12 | 100% | 3% | 25%wc | 25%wc | 100% | 100% | 75%hwc | 75%hwc | 75%hwc | 75%hwc | |
| L13 | 100% | 3% | 25%wc | 25%wc | 100% | 100% | 75%hwc | 40%wc | 40%wc | 40%wc | |
| L14 | 100% | 3% | 25%wc | 25%wc | 100% | 100% | 40%wc | 75%hwc | 75%hwc | 40%wc | |
| L15 | 100% | 3% | 25%wc | 25%wc | 100% | 100% | 40%wc | 40%wc | 40%wc | 75%hwc | |
| L99 | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | |
ActRelease.
Figure 2Flowchart of observed events and simulated options and scenarios for the 3 phases of the COVID-19 outbreak in the studied area.
Economic scenarios and global production for the 4 active populations.
| E0 | 25% | 0% | 66% | 66% |
| E1 | ActReleasePopi, Lj | |||
| E2 | ActReleasePopi, Lj | ActReleasePopi, Lj + 25% | ActReleasePopi, Lj | |
| E3 | ActReleasePopi, Lj | ActReleasePopi, Lj + 25% | ||
| E4 | ActReleasePopi, Lj + 15% | |||
| E5 | ActReleasePopi, Lj – 5% | |||
| 326 | 326 | 423 | 571 | |
Parameters, values, and sources to define the bioeconomic model.
| Young | 12.00 | 1.44 | 3.12 | 1.20 | 1.08 | 1.08 | 3.60 | 3.12 | 2.40 | 1.20 |
| Students | 4.32 | 3.36 | 2.64 | 1.68 | 0.45 | 0.69 | 2.04 | 2.64 | 2.64 | 2.52 |
| Unemployed | 4.32 | 3.36 | 2.64 | 1.68 | 0.66 | 0.45 | 2.04 | 2.64 | 2.64 | 2.64 |
| Senior | 0.30 | 0.60 | 3.12 | 8.40 | 0.42 | 0.42 | 2.40 | 2.40 | 1.68 | 0.12 |
| Medical | 4.32 | 3.36 | 2.64 | 1.68 | 0.66 | 0.45 | 2.04 | 2.64 | 2.64 | 2.64 |
| Essentials | 4.32 | 3.36 | 2.64 | 1.68 | 0.45 | 0.69 | 2.04 | 2.64 | 2.64 | 2.52 |
| Active_lower | 3.60 | 2.40 | 3.60 | 2.40 | 0.51 | 0.51 | 2.88 | 2.52 | 2.52 | 2.40 |
| Active_fixed | 3.12 | 2.4 | 4.44 | 2.40 | 0.66 | 0.66 | 2.52 | 4.56 | 1.20 | 0.48 |
| Active_Intermediate | 2.40 | 2.4 | 0.84 | 1.68 | 0.66 | 0.66 | 2.52 | 1.20 | 6.00 | 4.08 |
| Active_higher | 1.20 | 4.44 | 0.12 | 0.12 | 0.66 | 0.63 | 2.40 | 0.48 | 4.08 | 8.40 |
Matrix contact () for the different populations.
| Θ−1 | Incubation period | 5.2 d | 1 |
| Duration of prodromal phase | 1.5 d, computed as the fraction of pre-symptomatic transmission events out of pre-symptomatic plus symptomatic transmission events | 2 | |
| ϵ−1 | Latency period | Θ−1 - | – |
| pa | Probability of being asymptomatic | 0.2, 05 | 3 |
| pps | If symptomatic, probability of being paucisymptomatic | 1 for children | 4 |
| pms | If symptomatic, probability of developing mild symptoms | 0 for children | 4 |
| pss | If symptomatic, probability of developing severe symptoms | 0 for children | 4–6 |
| s | Serial interval | 7.5 d | 7 |
| μ−1 | Infectious period for Ia, Ips, Ims, Iss | S - Θ−1 | – |
| rβ | Relative infectiousness of Ip, Ia, Ips | 0.51 | 8 |
| p ICU | If severe symptoms, probability of going in ICU | 0 for children | 9 |
| λ H, R | If hospitalized, daily rate entering in R | 0 for children | 9 |
| λ H, D | If hospitalized, daily rate in D | 0 for children | 9 |
| λ ICU, R | If in ICU, daily rate entering in R | 0 for children | 9 |
| λ ICU, D | If in ICU, daily rate entering in D | 0 for children | 9 |
Figure 3Epidemiologic validation of the model. (A) Comparison between the predicted (solid line) and observed (dashed line) number of day-beds used. (B–F) Number of daily beds used in hospital (CIU excluded). The red dashed line represents the hospital capacity. Tr, transmission rate; Option 1, abrupt monitored lockdown lift early in phase 2; Option 3, progressive monitored lockdown lift on 8 weeks; Option O34, progressive total lockdown lift (phase 3).
Figure 4Number of daily beds used in the hospital (ICU excluded) for the different scenarios (L1 to L15). Tr, transmission rate; the red dashed line represents the hospital capacity. Option O34 (left), progressive total lockdown lift (phase 3); Option O34 (right), abrupt total lockdown lift (phase 3).
Figure 5Graphical representation of the optimal solution depending on the strength of the constraint for a whole period of 300 days. The results in the right column are expressed as direct cost (in billion euros); Tr, transmission rate. The optimal solution that minimizes the overall economic impact under a set of constraints is found in the foreground (low mortality, high welfare, and low saturation).
Figure 6Graphical representation of the optimal solution depending on the strength of the constraint for a whole period of 600 days. The results in the right column are expressed as direct cost (in billion euros); Tr, transmission rate. The optimal solution that minimizes the overall economic impact under a set of constraints is found in the foreground (low mortality, high welfare, and low saturation).